XML 56 R45.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments, Risk Management and Fair Value Measurements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Fair Value Disclosures [Abstract] |
Schedule of Fair Value Of Financial Instruments, Valuation Method | The carrying value of these financial instruments approximates their fair value. Our other financial instruments include the following:
Financial Instrument |  | Valuation Method
Foreign exchange forward contracts |  | Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on current market prices for applicable currencies.
Commodity forward contracts |  | Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices for applicable commodities.
Cross currency swaps |  | Estimated amounts that would be received or paid to terminate the contracts at the reporting date based on discounted remaining cash flows for applicable currencies.
Debt |  | Our estimates and information obtained from independent third parties using market data, such as bid/ask spreads for the last business day of the reporting period.
Schedule of Derivative Instruments In Statement of Financial Position, Fair Value | The following tables provide the gross fair value and net balance sheet presentation of our derivative instruments.
| September 30, 2025
| Gross Amount of Derivatives |  |  |  |  |  |
(in Millions) | Designated as Cash Flow Hedges |  | Designated as Net Investment Hedges |  | Not Designated as Hedging Instruments |  | Total Gross Amounts |  | Gross Amounts Subject to Master Netting Arrangements |  | Net Amounts
Foreign exchange contracts | $ | 12.0 |  |  | $ | — |  |  | $ | 17.9 |  |  | $ | 29.9 |  |  | $ | (29.6) |  |  | $ | 0.3 |
Total derivative assets (1) | $ | 12.0 |  |  | $ | — |  |  | $ | 17.9 |  |  | $ | 29.9 |  |  | $ | (29.6) |  |  | $ | 0.3 |
Foreign exchange contracts | $ | (37.8) |  |  | $ | (3.6) |  |  | $ | (27.8) |  |  | $ | (69.2) |  |  | $ | 29.6 |  |  | $ | (39.6) |
Total derivative liabilities (2) | $ | (37.8) |  |  | $ | (3.6) |  |  | $ | (27.8) |  |  | $ | (69.2) |  |  | $ | 29.6 |  |  | $ | (39.6) |
Net derivative assets (liabilities) | $ | (25.8) |  |  | $ | (3.6) |  |  | $ | (9.9) |  |  | $ | (39.3) |  |  | $ | — |  |  | $ | (39.3) |
| December 31, 2024
| Gross Amount of Derivatives |  |
(in Millions) | Designated as Cash Flow Hedges |  | Designated as Net Investment Hedges |  | Not Designated as Hedging Instruments |  | Total Gross Amounts |  | Gross Amounts Subject to Master Netting Arrangements |  | Net Amounts
Foreign exchange contracts | $ | 25.0 |  |  | $ | — |  |  | $ | 22.0 |  |  | $ | 47.0 |  |  | $ | (12.9) |  |  | $ | 34.1 |
Total derivative assets (1) | $ | 25.0 |  |  | $ | — |  |  | $ | 22.0 |  |  | $ | 47.0 |  |  | $ | (12.9) |  |  | $ | 34.1 |
Foreign exchange contracts | $ | (8.3) |  |  | $ | — |  |  | $ | (4.6) |  |  | $ | (12.9) |  |  | $ | 12.9 |  |  | $ | — |
Total derivative liabilities (2) | $ | (8.3) |  |  | $ | — |  |  | $ | (4.6) |  |  | $ | (12.9) |  |  | $ | 12.9 |  |  | $ | — |
Net derivative assets (liabilities) | $ | 16.7 |  |  | $ | — |  |  | $ | 17.4 |  |  | $ | 34.1 |  |  | $ | — |  |  | $ | 34.1 |
______________ (1) Balance is included in "Prepaid and other current assets" in the consolidated balance sheets. (2) Balance is included in "Accrued and other liabilities" in the consolidated balance sheets.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The tables below summarize the gains or losses related to our cash flow hedges and derivatives not designated as hedging instruments. Derivatives in Cash Flow Hedging Relationships
| Contracts |  |
| Foreign Exchange |  |  |  | Interest rate |  | Total
| Three Months Ended September 30,
(in Millions) | 2025 |  | 2024 |  |  |  |  |  | 2025 |  | 2024 |  | 2025 |  | 2024
Unrealized hedging gains (losses) and other, net of tax | $ | 28.7 |  |  | $ | (10.2) |  |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | 28.7 |  |  | $ | (10.2) |
Reclassification of deferred hedging (gains) losses, net of tax (1) | (19.4) |  |  | 5.1 |  |  |  |  |  |  | 0.4 |  |  | 0.4 |  |  | (19.0) |  |  | 5.5 |
Total derivative instrument impact on comprehensive income, net of tax | $ | 9.3 |  |  | $ | (5.1) |  |  |  |  |  |  | $ | 0.4 |  |  | $ | 0.4 |  |  | $ | 9.7 |  |  | $ | (4.7) |
| Contracts |  |
| Foreign Exchange |  |  |  | Interest rate |  | Total
| Nine Months Ended September 30,
(in Millions) | 2025 |  | 2024 |  |  |  |  |  | 2025 |  | 2024 |  | 2025 |  | 2024
Unrealized hedging gains (losses) and other, net of tax | $ | (8.0) |  |  | $ | 10.9 |  |  |  |  |  |  | $ | — |  |  | $ | — |  |  | $ | (8.0) |  |  | $ | 10.9 |
Reclassification of deferred hedging (gains) losses, net of tax (1) | (21.3) |  |  | 5.5 |  |  |  |  |  |  | 1.1 |  |  | 1.1 |  |  | (20.2) |  |  | 6.6 |
Total derivative instrument impact on comprehensive income, net of tax | $ | (29.3) |  |  | $ | 16.4 |  |  |  |  |  |  | $ | 1.1 |  |  | $ | 1.1 |  |  | $ | (28.2) |  |  | $ | 17.5 |
______________ (1)See Note 13 for classification of amounts within the consolidated statements of income (loss). Derivatives Not Designated as Hedging Instruments
|  |  | Amount of Pre-tax Gain (Loss) Recognized in Income on Derivatives (1)
|  |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in Millions) |  |  | 2025 |  | 2024 |  | 2025 |  | 2024
Foreign exchange contracts |  |  | $ | (7.7) |  |  | $ | 4.5 |  |  | $ | (23.2) |  |  | $ | (8.5) |
Total |  |  | $ | (7.7) |  |  | $ | 4.5 |  |  | $ | (23.2) |  |  | $ | (8.5) |
______________ (1)Amounts in the columns represent the gain or loss on the derivative instrument offset by the gain or loss on the hedged item. These amounts are included in "Costs of sales and services" and to a lesser extent "Selling, general, and administrative expenses" on the consolidated statements of income (loss).
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following tables present our fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis in the consolidated balance sheets. During the periods presented there were no transfers between fair value hierarchy levels.
(in Millions) | September 30, 2025 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 0.3 |  |  | $ | — |  |  | $ | 0.3 |  |  | $ | — |
Other (2) (3) (4) | 309.6 |  |  | 269.5 |  |  | — |  |  | 40.1 |
Total assets | $ | 309.9 |  |  | $ | 269.5 |  |  | $ | 0.3 |  |  | $ | 40.1 |
Liabilities |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 39.6 |  |  | $ | — |  |  | $ | 39.6 |  |  | $ | — |
Other (2) | 20.7 |  |  | 20.7 |  |  | — |  |  | — |
Total liabilities | $ | 60.3 |  |  | $ | 20.7 |  |  | $ | 39.6 |  |  | $ | — |
(in Millions) | December 31, 2024 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Assets |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | 34.1 |  |  | $ | — |  |  | $ | 34.1 |  |  | $ | — |
Other (2) (3) (4) | 120.1 |  |  | 84.1 |  |  | — |  |  | 36.0 |
Total assets | $ | 154.2 |  |  | $ | 84.1 |  |  | $ | 34.1 |  |  | $ | 36.0 |
Liabilities |  |  |  |  |  |  |
Derivatives – Foreign exchange (1) | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Other (2) | 23.2 |  |  | 23.2 |  |  | — |  |  | — |
Total liabilities | $ | 23.2 |  |  | $ | 23.2 |  |  | $ | — |  |  | $ | — |
____________________ (1)See the Fair Value of Derivative Instruments table within this Note for classification on the consolidated balance sheets. (2)Consists of a deferred compensation arrangement, through which we hold various investment securities, recognized on our balance sheets. Both the asset and liability are recorded at fair value. Asset amounts are included in "Other assets including long-term receivables, net" in the consolidated balance sheets. Liability amounts are included in "Other long-term liabilities" in the consolidated balance sheets. (3)FMC maintains a beneficial interest in a trade receivables securitization fund. The fair value of the beneficial interest is determined by calculating the expected amount of cash to be received on the fund’s outstanding credit notes. As part of this evaluation, we rely on unobservable inputs, including estimating the anticipated credit losses. We consider historical information, current conditions and other reasonable factors as part of this assessment. The amount is included in "Other assets including long-term receivables, net" in the consolidated balance sheets. (4)Includes money market funds, which consist of highly liquid investments valued at quoted market prices, recognized as "Cash and cash equivalents" on our consolidated balance sheets.
Schedule of Fair Value Measurements, Nonrecurring | The following table presents our fair value hierarchy for those assets and liabilities measured at fair value on a nonrecurring basis in the consolidated balance sheets during the nine months ended September 30, 2025.
|  | September 30, 2025 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total Gains (Losses) (During the nine months ended September 30, 2025)
Assets |  |  |  |  |  |  |  |  |  |
Net assets related to India held for sale business (1) |  | $ | 450.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 450.0 |  |  | $ | (226.8) |
Total assets |  | $ | 450.0 |  |  | $ | — |  |  | $ | — |  |  | $ | 450.0 |  |  | $ | (226.8) |
____________________ (1)During the nine months ended September 30, 2025, we evaluated the carrying value of the assets related to the sale of our India commercial business following one-time commercial actions recorded to prepare the business for sale. We recorded an impairment charge of $226.8 million bringing the assets to their estimated fair value less costs to sell resulting in net assets identified as held for sale of $450 million, as presented on the consolidated balance sheet as of September 30, 2025. The fair value of the net assets was determined by considering a discounted cash flow analysis and as part of this evaluation, we rely on unobservable inputs, including forecasts of the India commercial business developed by management. Refer to Note 1 for further details on the India held for sale business.

X
- Definition Schedule Of Fair Value Of Financial Instruments, Valuation Method + References No definition available. + Details
Name: | fmc_ScheduleOfFairValueOfFinancialInstrumentsValuationMethodTableTextBlock
Namespace Prefix: | fmc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 182 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480401/815-10-55-182 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration